Screener
BioMarin Pharmaceuticals BMRN Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| ASSETS | June 30, 2026 / (unaudited) | December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Intangible assets, net | 4,879,367 | 213,837 |
| Goodwill | 655,745 | 196,199 |
| Deferred tax assets | 888,575 | 1,508,697 |
| Other assets | 338,138 | 277,049 |
| Total assets | $11,723,442 | $7,594,022 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $1,005,793 | $759,031 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's other non-current assets?
- BioMarin Pharmaceuticals (BMRN) reported other non-current assets of $338.14M in Q2 2026.
- How has BioMarin Pharmaceuticals's other non-current assets changed year-over-year?
- BioMarin Pharmaceuticals's other non-current assets increased by 35.7% year-over-year, from $249.19M to $338.14M.
- What is the long-term trend for BioMarin Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's other non-current assets has grown at a 14.3% compound annual growth rate (CAGR), from $142.24M to $277.05M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about BioMarin Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude